Honeywell – Honeywell and Recipharm to Speed Development of Inhalers with a Near-Zero Global Warming Potential Propellant

August 17, 2023
Honeywell

Partnership will reduce environmental footprint of pressurized metered dose inhalers and accelerate transition to lower greenhouse gas respiratory care.

 

MORRIS PLAINS, N.J. and STOCKHOLM, Aug. 17, 2023 /PRNewswire/ — Honeywell (Nasdaq: HON) and global contract development and manufacturing organization (CDMO) Recipharm have today announced a commercial partnership that will speed the development of pressurized metered dose inhalers (pMDIs) that use Honeywell’s near-zero global warming potential (GWP) propellant.

…